Steris PLC (STE): Price and Financial Metrics


Steris PLC (STE): $206.10

1.18 (+0.58%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

STE POWR Grades

  • Sentiment is the dimension where STE ranks best; there it ranks ahead of 86.56% of US stocks.
  • The strongest trend for STE is in Growth, which has been heading down over the past 177 days.
  • STE ranks lowest in Momentum; there it ranks in the 10th percentile.

STE Stock Summary

  • With a market capitalization of $20,455,719,529, STERIS PLC has a greater market value than 89.86% of US stocks.
  • STE's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 4,015.11 -- higher than 99.21% of US-listed equities with positive expected earnings growth.
  • The price/operating cash flow metric for STERIS PLC is higher than 79.62% of stocks in our set with a positive cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to STERIS PLC are DGICA, TTD, IAS, CTKB, and DDOG.
  • Visit STE's SEC page to see the company's official filings. To visit the company's web site, go to www.steris.com.

STE Valuation Summary

  • STE's price/sales ratio is 4.3; this is 15.69% lower than that of the median Healthcare stock.
  • STE's price/earnings ratio has moved down 2622.2 over the prior 99 months.

Below are key valuation metrics over time for STE.

Stock Date P/S P/B P/E EV/EBIT
STE 2023-01-20 4.3 3.5 -2515.6 155.6
STE 2023-01-19 4.2 3.4 -2442.8 151.7
STE 2023-01-18 4.1 3.4 -2393.4 149.0
STE 2023-01-17 4.2 3.4 -2451.5 152.1
STE 2023-01-13 4.2 3.5 -2477.8 153.6
STE 2023-01-12 4.2 3.4 -2455.8 152.4

STE Growth Metrics

    Its 4 year price growth rate is now at 115.16%.
  • Its 4 year net cashflow from operations growth rate is now at 39.25%.
  • The 3 year price growth rate now stands at 71.13%.
Over the past 33 months, STE's revenue has gone up $1,800,548,000.

The table below shows STE's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 4,776.665 751.615 -8.139
2022-06-30 4,773.133 819.131 376.957
2022-03-31 4,585.064 684.811 243.888
2021-12-31 4,247.909 700.935 280.478
2021-09-30 3,847.862 662.333 251.356
2021-06-30 3,407.009 652.944 287.403

STE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • STE has a Quality Grade of C, ranking ahead of 30.1% of graded US stocks.
  • STE's asset turnover comes in at 0.443 -- ranking 107th of 186 Medical Equipment stocks.
  • NVCR, BSGM, and NUWE are the stocks whose asset turnover ratios are most correlated with STE.

The table below shows STE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.443 0.436 0.106
2021-03-31 0.518 0.432 0.168
2020-12-31 0.535 0.434 0.180
2020-09-30 0.559 0.434 0.191
2020-06-30 0.564 0.433 0.185
2020-03-31 0.572 0.435 0.183

STE Price Target

For more insight on analysts targets of STE, see our STE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $249.60 Average Broker Recommendation 1.3 (Strong Buy)

STE Stock Price Chart Interactive Chart >

Price chart for STE

STE Price/Volume Stats

Current price $206.10 52-week high $255.93
Prev. close $204.92 52-week low $159.21
Day low $203.54 Volume 276,900
Day high $206.36 Avg. volume 418,817
50-day MA $188.50 Dividend yield 0.91%
200-day MA $199.62 Market Cap 20.57B

Steris PLC (STE) Company Bio


Steris Corporation is an Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system.[4] Steris is operationally headquartered in MentorOhio,[1] but has been legally registered since 2018 in DublinIreland for tax purposes; it was previously registered in the United Kingdom from 2014 to 2018. Steris is quoted on the NYSE, and is a constituent of the S&P 500 Index (Source:Wikipedia)


STE Latest News Stream


Event/Time News Detail
Loading, please wait...

STE Latest Social Stream


Loading social stream, please wait...

View Full STE Social Stream

Latest STE News From Around the Web

Below are the latest news stories about STERIS PLC that investors may wish to consider to help them evaluate STE as an investment opportunity.

STERIS to Host a Conference Call for Fiscal 2023 Third Quarter Financial Results on February 9, 2023

DUBLIN, IRELAND, Jan. 25, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 third quarter financial results at 10:00 a.m. ET on February 9, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter

Yahoo | January 25, 2023

STERIS plc (Ireland) – Consensus Indicates Potential 15.5% Upside

STERIS plc (Ireland) found using ticker (STE) have now 5 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 250 and 190 calculating the mean target price we have 221. With the stocks previous close at 191.32 this now indicates there is a potential upside of 15.5%. There is a 50 day moving average of 178.68 and the 200 day MA is 202.79. The company has a market capitalisation of $18,696m. Find out more information at: https://www.steris.com [stock_market_widget type="chart" template="basic" color="green" assets="STE" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $21,596m based on the market concensus. STERIS plc provides infection prevention and ot...

DirectorsTalk | January 6, 2023

Endoscope Reprocessing Global Market Report 2022: Ukraine-Russia War Impact

Major players in the endoscope reprocessing market are Custom Ultrasonics, Advanced Sterilization Products Inc, Olympus Corporation, Wassenburg Medical BV, Steris Corporation, Getinge AB, ARC Healthcare Solutions, BES Healthcare Ltd, Medonica Company LTD, Borer Chemie AG, Metrex Research LLC, Matachana Group, HOYA Corporation, Laboratories Anios, CONMED Corporation, Endo-Technik W. Major players in the endoscope reprocessing market are Custom Ultrasonics, Advanced Sterilization Products Inc, Olympus Corporation, Wassenburg Medical BV, Steris Corporation, Getinge AB, ARC Healthcare Solutions, BES Healthcare Ltd, Medonica Company LTD, Borer Chemie AG, Metrex Research LLC, Matachana Group, HOYA Corporation, Laboratories Anios, CONMED Corporation, Endo-Technik W.

GlobeNewswire | January 4, 2023

Steris Plc STE Investment Analysis and Advice

Timing Trades in Steris Plc STE can be Risky if you Don''t Have Discipline

Stock Traders Daily | December 25, 2022

Estimating The Intrinsic Value Of STERIS plc (NYSE:STE)

Today we will run through one way of estimating the intrinsic value of STERIS plc ( NYSE:STE ) by taking the expected...

Yahoo | December 25, 2022

Read More 'STE' Stories Here

STE Price Returns

1-mo 11.59%
3-mo 19.76%
6-mo -7.69%
1-year -5.40%
3-year 38.03%
5-year 134.40%
YTD 11.59%
2022 -23.43%
2021 29.47%
2020 25.50%
2019 44.09%
2018 23.66%

STE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full STE Dividend History

Continue Researching STE

Here are a few links from around the web to help you further your research on STERIS plc's stock as an investment opportunity:

STERIS plc (STE) Stock Price | Nasdaq
STERIS plc (STE) Stock Quote, History and News - Yahoo Finance
STERIS plc (STE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7376 seconds.